Role of Rho GTPases and their regulators in cancer progression

Frontiers in Bioscience

Volumn 16, Issue 7, 2011, Pages 2561-2571

  Rathinam, Rajamani ^a   Berrier, Allison ^b   Alahari, Suresh K ^a,c  

^a Stanley Scott Cancer Center   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Cancer progression; GTPases; Regulators; Review; Rho

Indexed keywords

GUANINE NUCLEOTIDE EXCHANGE FACTOR; INTEGRIN; PROTEIN CDC42; RAC1 PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL; BIOLOGICAL MODEL; DISEASE COURSE; HUMAN; METABOLISM; NEOPLASM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CDC42 GTP-BINDING PROTEIN; DISEASE PROGRESSION; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; INTEGRINS; MODELS, BIOLOGICAL; NEOPLASMS; RAC1 GTP-BINDING PROTEIN; RHO GTP-BINDING PROTEINS; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION;

EID: 79959559880     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3872     Document Type: Article

References (76)

1. F. Grise, A. Bidaud and V. Moreau: Rho GTPases in hepatocellular carcinoma. Biochim Biophys Acta, 1795(2), 137-51 (2009)
2. A. Hall: The cytoskeleton and cancer. Cancer Metastasis Rev, 28(1-2), 5-14 (2009)
3. P. Burbelo, A. Wellstein and R. G. Pestell: Altered Rho GTPase signaling pathways in breast cancer cells. Breast Cancer Res Treat, 84(1), 43-8 (2004) (Pubitemid 38388859)
4. C. D. Nobes and A. Hall: Rho, rac, and CDC42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell, 81(1), 53-62 (1995)
5. A. Hall: Rho GTPases and the actin cytoskeleton. Science, 279(5350), 509-14 (1998) (Pubitemid 28067271)
6. B. Harmon, N. Campbell and L. Ratner: Role of Abl kinase and the Wave2 signaling complex in HIV-1 entry at a post-hemifusion step. PLoS Pathog, 6(6), (2010)
7. A. Y. Chan, S. J. Coniglio, Y. Y. Chuang, D. Michaelson, U. G. Knaus, M. R. Philips and M. Symons: Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion. Oncogene, 24(53), 7821-9 (2005) (Pubitemid 41715188)
8. S. D. Merajver and S. Z. Usmani: Multifaceted role of Rho proteins in angiogenesis. J Mammary Gland Biol Neoplasia, 10(4), 291-8 (2005) (Pubitemid 44256409)
9. J. M. Bristow, M. H. Sellers, D. Majumdar, B. Anderson, L. Hu and D. J. Webb: The Rho-family GEF Asef2 activates Rac to modulate adhesion and actin dynamics and thereby regulate cell migration. J Cell Sci, 122(Pt 24), 4535-46 (2009)
10. L. Sequeira, C. W. Dubyk, T. A. Riesenberger, C. R. Cooper and K. L. van Golen: Rho GTPases in PC-3 prostate cancer cell morphology, invasion and tumorcell diapedesis. Clin Exp Metastasis, 25(5), 569-79 (2008)
11. H. Lue, M. Dewor, L. Leng, R. Bucala and J. Bernhagen: Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74. Cell Signal, 23(1), 135-44 (2011)
12. Y. Zhang, L. A. Rivera Rosado, S. Y. Moon and B. Zhang: Silencing of D4-GDI inhibits growth and invasive behavior in MDA-MB-231 cells by activation of Rac-dependent p38 and JNK signaling. J Biol Chem, 284(19), 12956-65 (2009)
13. S. Liu, M. Yu, Y. He, L. Xiao, F. Wang, C. Song, S. Sun, C. Ling and Z. Xu: Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway. Hepatology, 47(6), 1964-73 (2008) (Pubitemid 351945563)
14. G. Sala, F. Dituri, C. Raimondi, S. Previdi, T. Maffucci, M. Mazzoletti, C. Rossi, M. Iezzi, R. Lattanzio, M. Piantelli, S. Iacobelli, M. Broggini and M. Falasca: Phospholipase Cgamma1 is required for metastasis development and progression. Cancer Res, 68(24), 10187-96 (2008)
15. L. Chen, J. J. Zhang and X. Y. Huang: cAMP inhibits cell migration by interfering with Rac-induced lamellipodium formation. J Biol Chem, 283(20), 13799-805 (2008)
16. D. Wu, M. Asiedu and Q. Wei: Myosin-interacting guanine exchange factor (MyoGEF) regulates the invasion activity of MDA-MB-231 breast cancer cells through activation of RhoA and RhoC. Oncogene, 28(22), 2219-30 (2009)
17. P. Dua and R. P. Gude: Pentoxifylline impedes migration in B16F10 melanoma by modulating Rho GTPase activity and actin organisation. Eur J Cancer, 44(11), 1587-95 (2008)
18. M. Yanagisawa, D. Huveldt, P. Kreinest, C. M. Lohse, J. C. Cheville, A. S. Parker, J. A. Copland and P. Z. Anastasiadis: A p120 catenin isoform switch affects RhoActivity, induces tumor cell invasion, and predicts metastatic disease. J Biol Chem, 283(26), 18344-54 (2008)
19. M. El-Sibai, O. Pertz, H. Pang, S. C. Yip, M. Lorenz, M. Symons, J. S. Condeelis, K. M. Hahn and J. M. Backer: RhoA/ROCK-mediated switching between CDC42-and Rac1-dependent protrusion in MTLn3 carcinoma cells. Exp Cell Res, 314(7), 1540-52 (2008)
20. J. Deplazes, M. Fuchs, S. Rauser, H. Genth, E. Lengyel, R. Busch and B. Luber: Rac1 and Rho contribute to the migratory and invasive phenotype associated with somatic E-cadherin mutation. Hum Mol Genet, 18(19), 3632-44 (2009)
21. Y. Liu, Q. C. Li, Y. Miao, H. T. Xu, S. D. Dai, Q. Wei, Q. Z. Dong, X. J. Dong, Y. Zhao, C. Zhao and E. H. Wang: Ablation of p120-catenin enhances invasion and metastasis of human lung cancer cells. Cancer Sci, 100(3), 441-8 (2009)
22. L. Baisamy, S. Cavin, N. Jurisch and D. Diviani: The ubiquitin-like protein LC3 regulates the Rho-GEF activity of AKAP-Lbc. J Biol Chem, 284(41), 28232-42 (2009)
23. A. Horiuchi, T. Imai, C. Wang, S. Ohira, Y. Feng, T. Nikaido and I. Konishi: Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma. Lab Invest, 83(6), 861-70 (2003) (Pubitemid 36723695)
24. T. Kamai, T. Tsujii, K. Arai, K. Takagi, H. Asami, Y. Ito and H. Oshima: Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin Cancer Res, 9(7), 2632-41 (2003) (Pubitemid 36842107)
25. Y. Pan, F. Bi, N. Liu, Y. Xue, X. Yao, Y. Zheng and D. Fan: Expression of seven main Rho family members in gastric carcinoma. Biochem Biophys Res Commun, 315(3), 686-91 (2004) (Pubitemid 38229398)
26. W. G. Jiang, G. Watkins, J. Lane, G. H. Cunnick, A. Douglas-Jones, K. Mokbel and R. E. Mansel: Prognostic value of rho GTPases and rho guanine nucleotide dissociation inhibitors in human breast cancers. Clin Cancer Res, 9(17), 6432-40 (2003) (Pubitemid 38031830)
27. T. Kamai, T. Yamanishi, H. Shirataki, K. Takagi, H. Asami, Y. Ito and K. Yoshida: Overexpression of RhoA, Rac1, and CDC42 GTPases is associated with progression in testicular cancer. Clin Cancer Res, 10(14), 4799-805 (2004) (Pubitemid 38955533)
28. L. E. Arias-Romero, O. Villamar-Cruz, A. Pacheco, R. Kosoff, M. Huang, S. K. Muthuswamy and J. Chernoff: A Rac-Pak signaling pathway is essential for ErbB2-mediated transformation of human breast epithelial cancer cells. Oncogene 29(43), 5839-49 (2010)
29. S. J. Heasman and A. J. Ridley: Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat Rev Mol Cell Biol, 9(9), 690-701 (2008)
30. G. Gadea, V. Sanz-Moreno, A. Self, A. Godi and C. J. Marshall: DOCK10-mediated CDC42 activation is necessary for amoeboid invasion of melanoma cells. Curr Biol, 18(19), 1456-65 (2008)
31. C. Ambrogio, C. Voena, A. D. Manazza, C. Martinengo, C. Costa, T. Kirchhausen, E. Hirsch, G. Inghirami and R. Chiarle: The anaplastic lymphoma kinase controls cell shape and growth of anaplastic large cell lymphoma through CDC42 activation. Cancer Res, 68(21), 8899-907 (2008)
32. D. M. Appledorn, K. H. Dao, S. O'Reilly, V. M. Maher and J. J. McCormick: Rac1 and CDC42 are regulators of HRasV12-transformation and angiogenic factors in human fibroblasts. BMC Cancer, 10, 13(2010)
33. Y. Ohta, L. Fujimura, S. Nishio, M. Arima, A. Sakamoto, H. Shimada, T. Ochiai, T. Tokuhisa and M. Hatano: A kelch family protein Nd1-L functions as a metastasis suppressor in cancer cells via Rho family proteins mediated mechanism. Int J Oncol, 36(2), 427-34(2010)
34. G. Fritz, I. Just and B. Kaina: Rho GTPases are overexpressed in human tumors. Int J Cancer, 81(5), 682-7 (1999) (Pubitemid 29214373)
35. L. Yang, L. Wang, T. A. Kalfa, J. A. Cancelas, X. Shang, S. Pushkaran, J. Mo, D. A. Williams and Y. Zheng: CDC42 critically regulates the balance between myelopoiesis and erythropoiesis. Blood, 110(12), 3853-61 (2007) (Pubitemid 350248440)
36. A. Schmidt and A. Hall: Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. Genes Dev, 16(13), 1587-609 (2002) (Pubitemid 34743321)
37. M. E. Minard, L. S. Kim, J. E. Price and G. E. Gallick: The role of the guanine nucleotide exchange factor Tiam1 in cellular migration, invasion, adhesion and tumor progression. Breast Cancer Res Treat, 84(1), 21-32 (2004) (Pubitemid 38388857)
38. G. Toumaniantz, D. Ferland-McCollough, C. Cario-Toumaniantz, P. Pacaud and G. Loirand: The Rho protein exchange factor Vav3 regulates vascular smooth muscle cell proliferation and migration. Cardiovasc Res, 86(1), 131-40 (2010)
39. J. E. Waters, M. V. Astle, L. M. Ooms, D. Balamatsias, R. Gurung and C. A. Mitchell: P-Rex1 - a multidomain protein that regulates neurite differentiation. J Cell Sci, 121(Pt 17), 2892-903 (2008)
40. G. Upadhyay, W. Goessling, T. E. North, R. Xavier, L. I. Zon and V. Yajnik: Molecular association between betacatenin degradation complex and Rac guanine exchange factor DOCK4 is essential for Wnt/beta-catenin signaling. Oncogene, 27(44), 5845-55 (2008)
41. V. Justilien and A. P. Fields: Ect2 links the PKCiota-Par6alpha complex to Rac1 activation and cellular transformation. Oncogene, 28(41), 3597-607 (2009)
42. S. I. Ellenbroek and J. G. Collard: Rho GTPases: functions and association with cancer. Clin Exp Metastasis, 24(8), 657-72 (2007) (Pubitemid 50002983)
43. D. Wu, M. Asiedu, R. S. Adelstein and Q. Wei: A novel guanine nucleotide exchange factor MyoGEF is required for cytokinesis. Cell Cycle, 5(11), 1234-9 (2006) (Pubitemid 43845385)
44. Z. Liu, H. C. Adams, 3rd and I. P. Whitehead: The rhospecific guanine nucleotide exchange factor Dbs regulates breast cancer cell migration. J Biol Chem, 284(23), 15771-80 (2009)
45. S. Prag, M. Parsons, M. D. Keppler, S. M. Ameer-Beg, P. Barber, J. Hunt, A. J. Beavil, R. Calvert, M. Arpin, B. Vojnovic and T. Ng: Activated ezrin promotes cell migration through recruitment of the GEF Dbl to lipid rafts and preferential downstream activation of CDC42. Mol Biol Cell, 18(8), 2935-48 (2007) (Pubitemid 47235301)
46. N. Tatsis, D. A. Lannigan and I. G. Macara: The function of the p190 Rho GTPase-activating protein is controlled by its N-terminal GTP binding domain. J Biol Chem, 273(51), 34631-8 (1998) (Pubitemid 29008948)
47. A. Dovas and J. R. Couchman: RhoGDI: multiple functions in the regulation of Rho family GTPase activities. Biochem J, 390(Pt 1), 1-9 (2005) (Pubitemid 41192225)
48. M. B. Jones, H. Krutzsch, H. Shu, Y. Zhao, L. A. Liotta, E. C. Kohn and E. F. Petricoin, 3rd: Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer. Proteomics, 2(1), 76-84 (2002) (Pubitemid 34273101)
49. L. F. Su, R. Knoblauch and M. J. Garabedian: Rho GTPases as modulators of the estrogen receptor transcriptional response. J Biol Chem, 276(5), 3231-7 (2001)
50. Y. Zhang and B. Zhang: D4-GDI, a Rho GTPase regulator, promotes breast cancer cell invasiveness. Cancer Res, 66(11), 5592-8 (2006) (Pubitemid 43927109)
51. D. Theodorescu, L. M. Sapinoso, M. R. Conaway, G. Oxford, G. M. Hampton and H. F. Frierson, Jr.: Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer. Clin Cancer Res, 10(11), 3800-6 (2004) (Pubitemid 38697615)
52. A. C. Thirone, P. Speight, M. Zulys, O. D. Rotstein, K. Szaszi, S. F. Pedersen and A. Kapus: Hyperosmotic stressinduces Rho/Rho kinase/LIM kinase-mediated cofilin phosphorylation in tubular cells: key role in the osmotically triggered F-actin response. Am J Physiol Cell Physiol, 296(3), C463-75 (2009)
53. R. A. Gungabissoon and J. R. Bamburg: Regulation of growth cone actin dynamics by ADF/cofilin. J Histochem Cytochem, 51(4), 411-20 (2003) (Pubitemid 36418037)
54. R. Niwa, K. Nagata-Ohashi, M. Takeichi, K. Mizuno and T. Uemura: Control of actin reorganization by Slingshot, a family of phosphatases that dephosphorylate ADF/cofilin. Cell, 108(2), 233-46 (2002) (Pubitemid 34161143)
55. B. Boda, S. Alberi, I. Nikonenko, R. Node-Langlois, P. Jourdain, M. Moosmayer, L. Parisi-Jourdain and D. Muller: The mental retardation protein PAK3 contributes to synapse formation and plasticity in hippocampus. J Neurosci, 24(48), 10816-25 (2004) (Pubitemid 39602393)
56. L. Y. Chen, C. S. Rex, M. S. Casale, C. M. Gall and G. Lynch: Changes in synaptic morphology accompany actin signaling during LTP. J Neurosci, 27(20), 5363-72 (2007) (Pubitemid 46790170)
57. G. M. Bokoch: Biology of the p21-activated kinases. Annu Rev Biochem, 72, 743-81 (2003) (Pubitemid 36930459)
58. C. S. Rex, L. Y. Chen, A. Sharma, J. Liu, A. H. Babayan, C. M. Gall and G. Lynch: Different Rho GTPase-dependent signaling pathways initiate sequential steps in the consolidation of long-term potentiation. J Cell Biol, 186(1), 85-97 (2009)
59. K. Takahashi and K. Suzuki: Membrane transport of WAVE2 and lamellipodia formation require Pak1 that mediates phosphorylation and recruitment of stathmin/Op18 to Pak1-WAVE2-kinesin complex. Cell Signal, 21(5), 695-703 (2009)
60. B. A. Webb, S. Zhou, R. Eves, L. Shen, L. Jia and A. S. Mak: Phosphorylation of cortactin by p21-activated kinase. Arch Biochem Biophys, 456(2), 183-93 (2006) (Pubitemid 44880282)
61. J. W. Xie and S. Z. Haslam: Extracellular matrix, Rac1 signaling, and estrogen-induced proliferation in MCF-7 breast cancer cells. Breast Cancer Res Treat, 110(2), 257-68 (2008) (Pubitemid 351793875)
62. S. L. Payne, M. J. Hendrix and D. A. Kirschmann: Lysyl oxidase regulates actin filament formation through the p130(Cas)/Crk/DOCK180 signaling complex. J Cell Biochem, 98(4), 827-37 (2006) (Pubitemid 43993399)
63. M. Dokmanovic, D. S. Hirsch, Y. Shen and W. J. Wu: Rac1 contributes to trastuzumab resistance of breast cancer cells: Rac1 as a potential therapeutic target for the treatment of trastuzumab-resistant breast cancer. Mol Cancer Ther, 8(6), 1557-69 (2009)
64. J. M. Servitja, M. J. Marinissen, A. Sodhi, X. R. Bustelo and J. S. Gutkind: Rac1 function is required for Src-induced transformation. Evidence of a role for Tiam1 and Vav2 in Rac activation by Src. J Biol Chem, 278(36), 34339-46 (2003) (Pubitemid 37553278)
65. S. J. Ahn, K. W. Chung, R. A. Lee, I. A. Park, S. H. Lee, D. E. Park and D. Y. Noh: Overexpression of betaPix-a inhuman breast cancer tissues. Cancer Lett, 193(1), 99-107 (2003) (Pubitemid 36412083)
66. K. Mythreye and G. C. Blobe: The type III TGFbeta receptor regulates directional migration: new tricks for an old dog. Cell Cycle, 8(19), 3069-70 (2009)
67. S. G. Cho, Z. Yi, X. Pang, T. Yi, Y. Wang, J. Luo, Z. Wu, D. Li and M. Liu: Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor angiogenesis by suppressing Sp1-mediated VEGF expression and FAK/Rho GTPase activation. Cancer Res, 69(17), 7062-70 (2009)
68. R. Arulanandam, M. Geletu, H. Feracci and L. Raptis: Activated Rac1 requires gp130 for Stat3 activation, cell proliferation and migration. Exp Cell Res, 316(5), 875-86 (2010)
69. C. M. Wells and G. E. Jones: The emerging importance of group II PAKs. Biochem J, 425(3), 465-73
70. P. R. Molli, D. Q. Li, B. W. Murray, S. K. Rayala and R. Kumar: PAK signaling in oncogenesis. Oncogene, 28(28), 2545-55 (2009)
71. M. D. Larrea, S. A. Wander and J. M. Slingerland: p27 as Jekyll and Hyde: regulation of cell cycle and cell motility. Cell Cycle, 8(21), 3455-61 (2009)
72. D. Hoshino, T. Tomari, M. Nagano, N. Koshikawa and M. Seiki: A novel protein associated with membrane-type 1 matrix metalloproteinase binds p27(kip1) and regulates RhoA activation, actin remodeling, and matrigel invasion. J Biol Chem, 284(40), 27315-26 (2009)
73. A. E. Aplin, A. K. Howe and R. L. Juliano: Cell adhesion molecules, signal transduction and cell growth. Curr Opin Cell Biol, 11(6), 737-44 (1999)
74. R. Rathinam and S. K. Alahari: Important role of integrins in the cancer biology. Cancer Metastasis Rev, 29(1), 223-37(2010)
75. T. Ishikawa and R. H. Kramer: Sdc1 negatively modulates carcinoma cell motility and invasion. Exp Cell Res, 316(6), 951-65(2010)
76. A. Cerezo, M. C. Guadamillas, J. G. Goetz, S. Sanchez-Perales, E. Klein, R. K. Assoian and M. A. del Pozo: The absence of caveolin-1 increases proliferation and anchorageindependent growth by a Rac-dependent, Erk-independent mechanism. Mol Cell Biol, 29(18), 5046-59 (2009)